Skip to main content

This site is currently implementing core features and is not ready for patient use yet.

Active

Theravectys

Lentiviral vector-based immunotherapies

Manufacturers

Country
Czechia
Founded
2005
HQ City
HQ Address
28 Rue du Docteur Roux, 75015 Paris, France
Email
contact@theravectys.com
Phone
+33 1 84 17 36 00

About

Theravectys, spun off from Institut Pasteur in 2005 by Dr. Pierre Charneau, develops lentiviral vector vaccines and immunotherapies for CMV, TB, and cancer under exclusive licenses.

Vaccines

No data available

FAQ

No FAQ items available.